COVID-19-related encephalopathy presenting with aphasia resolving following tocilizumab treatment

Encephalopathy is emerging as a recurrent complication of COVID-19 yet remains poorly characterized. We report the case of a middle-aged woman with COVID-19-related encephalopathy presenting as expressive aphasia and inattentiveness, subsequently progressing to agitation and marked confusion. Brain...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of neuroimmunology 2020-12, Vol.349, p.577400-577400, Article 577400
Hauptverfasser:	Muccioli, Lorenzo, Pensato, Umberto, Cani, Ilaria, Guerra, Luca, Provini, Federica, Bordin, Giorgio, Riccioli, Luca Albini, Lodi, Raffaele, Tinuper, Paolo, Bisulli, Francesca
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies, Monoclonal, Humanized - therapeutic use Aphasia - etiology Brain Diseases - drug therapy Brain Diseases - immunology Brain Diseases - virology COVID-19 - complications COVID-19 - drug therapy COVID-19 - immunology Cytokine Release Syndrome - drug therapy Cytokine Release Syndrome - virology Cytokines Delirium Encephalitis Female Humans Immunotherapy Middle Aged Neurological SARS-COV-2 Short Communication
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!